KAREN SPRINGFIELD: Open Payments
NPI 1760766430 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 56 payments from 17 companies in 2025. Trend: 2023 $1,151 · 2024 $939 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $233 |
| Novo Nordisk Inc | 13 | $141 |
| ABBVIE INC. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Amgen Inc. | 4 | $59 |
| PFIZER INC. | 3 | $57 |
| Astellas Pharma US Inc | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
Products named: CAPLYTA, Ozempic, LEQVIO, SHINGRIX, Veozah, Wegovy, OTEZLA, QULIPTA.
Industry payments across CO — which companies pay providers there.
